InsidersTradesSigma
Follow the Parallax Health Sciences, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Technology sector, Parallax Health Sciences, INC. has published 1 public disclosures. Market capitalisation: €1,096.4bn. The latest transaction was disclosed on 17 March 2022 (J). Among the most active insiders: WITHROW EDWARD W III. The full history is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Parallax Health Sciences, INC. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,491.95.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,845 of 29,063 companies
71.3
score / 100
Value64
Quality79
FCF yld1.2%
Earn yld6.4%
EV/EBITDA8.1x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 March 2022
Declarations1 total
7,050,773 shares@ US$0.080.0001% mcap100.0% of flowCOMMON STOCKSEC:0001388410-22-000004:0
1 of 1 declaration
Acerca de Parallax Health Sciences, INC.
Parallax Health Sciences, INC. es una empresa de tecnología centrada en el desarrollo de soluciones de salud innovadoras. Cotiza en el mercado XNAS.